483 related articles for article (PubMed ID: 24946282)
1. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to hepatocellular carcinoma in alcoholic cirrhosis: the NCAN-PNPLA3-lipid connection?
Nault JC; Nahon P
J Hepatol; 2014 Nov; 61(5):971-2. PubMed ID: 25111177
[No Abstract] [Full Text] [Related]
3. Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study.
Wu MJ; Yuan C; Lu LL; An BQ; Xuan SY; Xin YN
Lipids Health Dis; 2016 Nov; 15(1):207. PubMed ID: 27887608
[TBL] [Abstract][Full Text] [Related]
4. Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.
Raksayot M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Treeprasertsuk S; Poovorawan Y; Tanaka Y; Tangkijvanich P
J Gastroenterol; 2019 May; 54(5):427-436. PubMed ID: 30506232
[TBL] [Abstract][Full Text] [Related]
5. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis.
Machado MV; Janeiro A; Miltenberger-Miltenyi G; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):438-43. PubMed ID: 24445728
[TBL] [Abstract][Full Text] [Related]
7. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
[TBL] [Abstract][Full Text] [Related]
8. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
9. N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease.
Agúndez JA; Ladero JM; Olivera M; Lozano L; Fernández-Arquero M; de laConcha EG; Díaz-Rubio M; Benitez J
Scand J Gastroenterol; 2002 Jan; 37(1):99-103. PubMed ID: 11858170
[TBL] [Abstract][Full Text] [Related]
10. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
[TBL] [Abstract][Full Text] [Related]
11. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.
Nischalke HD; Berger C; Luda C; Berg T; Müller T; Grünhage F; Lammert F; Coenen M; Krämer B; Körner C; Vidovic N; Oldenburg J; Nattermann J; Sauerbruch T; Spengler U
PLoS One; 2011; 6(11):e27087. PubMed ID: 22087248
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity.
Gorden A; Yang R; Yerges-Armstrong LM; Ryan KA; Speliotes E; Borecki IB; Harris TB; Chu X; Wood GC; Still CD; Shuldiner AR; Gerhard GS;
Hum Hered; 2013; 75(1):34-43. PubMed ID: 23594525
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients.
Nezi V; Deutsch M; Gazouli M; Alexopoulou A; Paparrigopoulos T; Liappas IA; Dourakis SP
Alcohol Clin Exp Res; 2013 Feb; 37(2):244-51. PubMed ID: 23009036
[TBL] [Abstract][Full Text] [Related]
15. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
[TBL] [Abstract][Full Text] [Related]
16. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
17. The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis.
Saffroy R; Pham P; Chiappini F; Gross-Goupil M; Castera L; Azoulay D; Barrier A; Samuel D; Debuire B; Lemoine A
Carcinogenesis; 2004 Aug; 25(8):1443-8. PubMed ID: 15033905
[TBL] [Abstract][Full Text] [Related]
18. Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder.
Mühleisen TW; Mattheisen M; Strohmaier J; Degenhardt F; Priebe L; Schultz CC; Breuer R; Meier S; Hoffmann P; ; Rivandeneira F; Hofman A; Uitterlinden AG; Moebus S; Gieger C; Emeny R; Ladwig KH; Wichmann HE; Schwarz M; Kammerer-Ciernioch J; Schlösser RG; Nenadic I; Sauer H; Mössner R; Maier W; Rujescu D; Lange C; Ophoff RA; Schulze TG; Rietschel M; Nöthen MM; Cichon S
Schizophr Res; 2012 Jun; 138(1):69-73. PubMed ID: 22497794
[TBL] [Abstract][Full Text] [Related]
19. [The effect of previous HBV infection on hepatocellular carcinoma with alcoholic liver disease].
Tokushige K; Hashimoto E; Tobari M; Yatsuji S; Takakura M; Taniai M; Shiratori K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Apr; 41(2):120-7. PubMed ID: 16734279
[TBL] [Abstract][Full Text] [Related]
20. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]